Prot# N49-02-12-202: REVISED Protocol for a Double-Blind, Placebo-Controlled, Randomized Comparison of the Efficacy and Safety of Celecoxib 200mg and Celecoxib 400mg QD in Treating the Signs and Symptoms of Psoriatic Arthritis

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date9/24/025/21/07

    Funding

    • Bristol-Myers Squibb Company (Agmt 04/23/15)